Latvia vs Netherlands: Screening rates for cancers in Europe
Latvia
46.7%
in 2022
Netherlands
45.7%
in 2022
Latvia rank
13th
Netherlands rank
15th
Screening rates for cancers in Europe over time
- Latvia
- Netherlands
How they compare
Latvia currently reports 46.7% against 45.7% in Netherlands, a difference of 1.0%.
The two have swapped places 1 time across 14 shared years of data; in 2009 it was Netherlands ahead.
Latvia ranks 13th and Netherlands ranks 15th of 23 countries.
Netherlands has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.9% | 66.3% | 51.4% | Netherlands |
| 2010s | 30.4% | 62.2% | 31.8% | Netherlands |
| 2020s | 38.5% | 49.7% | 11.2% | Netherlands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher screening rates for cancers in europe, Latvia or Netherlands?
- Latvia, at 46.7% against 45.7% in Netherlands as of 2022.
- What is the difference in screening rates for cancers in europe between Latvia and Netherlands?
- 1.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 14 years are reported by both, from 2009 to 2022.
- How do Latvia and Netherlands rank globally for screening rates for cancers in europe?
- Latvia ranks 13th and Netherlands ranks 15th of 23 countries.
- Where does this data come from?
- Eurostat (2024) β processed by Our World in Data, published as Screening rates for cancers in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of women aged 20 to 69 years who have been screened for cervical cancer within the previous 3 years.